MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$1,079,841K
(-388.28%↓ Y/Y)
Unrealized gain on
short-term investments
$72K
(-28.00%↓ Y/Y)
Net loss
-$1,079,586K
(-387.81%↓ Y/Y)
Foreign currency
translation adjustments
-$327K
(-645.00%↓ Y/Y)
Other income, net
$14,838K
(10.99%↑ Y/Y)
Total operating
expenses
$1,094,424K
(383.59%↑ Y/Y)
General and
administrative
$556,750K
(819.84%↑ Y/Y)
Research and development
$537,674K
(256.60%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
summitplc-logo_05fd32df-svg
Summit Therapeutics Inc. (SMMT)
summitplc-logo_05fd32df-svg
Summit Therapeutics Inc. (SMMT)